Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CSF3R |
Variant | N610H |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | CSF3R N610H lies within fibronectin type-III domain 5 of the Csf3r protein (UniProt.org). N610H confers a gain of function to the Csf3r protein as demonstrated by increased Stat3 phosphorylation and ligand independent cell growth in culture (PMID: 30348809). |
Associated Drug Resistance | |
Category Variants Paths |
CSF3R mutant CSF3R act mut CSF3R N610H |
Transcript | NM_000760.4 |
gDNA | chr1:g.36467858T>G |
cDNA | c.1828A>C |
Protein | p.N610H |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_156039.3 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_017000370 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
NM_172313.2 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
NM_000760 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_011540749 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
NM_156039.3 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
NM_172313 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_005270493.1 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
NM_172313.3 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
NM_156039 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
NM_000760.3 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_005270493 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_011540748.3 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
NM_000760.4 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_005270493.1 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_047446753.1 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_017000370.1 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_011540748 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_011540749.1 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
XM_011540749.1 | chr1:g.36467858T>G | c.1828A>C | p.N610H | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
CSF3R N610H | Advanced Solid Tumor | sensitive | Ruxolitinib | Preclinical - Cell culture | Actionable | In a preclinical study, Jakafi (ruxolitinib) inhibited growth of transformed cells expressing CSF3R N610H in culture (PMID: 30348809). | 30348809 |
CSF3R N610H | Advanced Solid Tumor | predicted - sensitive | Trametinib | Preclinical - Cell culture | Actionable | In a preclinical study, Mekinist (trametinib) inhibited growth of transformed cells expressing CSF3R N610H in culture (PMID: 30348809). | 30348809 |